Cero Therapeutics updates major holder stake
Cero Therapeutics Holdings, Inc. reported an updated ownership disclosure from shareholder Isaiah Tibbs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cero Therapeutics Holdings, Inc. reported an updated ownership disclosure from shareholder Isaiah Tibbs. Tibbs beneficially owns 2,089,000 shares of Cero Therapeutics common stock, representing 4.63% of the class, based on 45,112,406 shares outstanding as of the second quarter. All of these shares are reported with sole voting and sole dispositive power, with no shared voting or dispositive authority. The filing notes that the position now reflects ownership of 5 percent or less of the company’s common stock.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in CERO does Isaiah Tibbs report in this Schedule 13G/A?
What percentage of CERO’s common stock is owned by Isaiah Tibbs?
Does the filing indicate Isaiah Tibbs owns more than 5% of CERO?
AI-generated analysis. How Rhea-AI works. Not financial advice.